Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 454K 420K 385K 729K 50.01M 741K 5M 1.97M 24.42M 1.95M 1.91M 84.31M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.27M 17.82M 16.36M 30.95M 2.12B 31.49M 213M 83.5M 1.04B 82.8M 80.98M 3.58B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-31	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-14	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-04	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
23-10-01	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
23-09-29	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
23-08-15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-01	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
23-06-15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

Nov. 18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
24-05-16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
24-05-16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
23-10-05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
23-10-02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+1.22%	-3.38%	+48.88%	+162.97%	1,031B
JOHNSON & JOHNSON	+0.94%	-3.56%	+51.64%	+57.08%	595B
ABBVIE INC.	+3.08%	+0.73%	+32.09%	+86.70%	431B
ROCHE HOLDING AG	+0.42%	-1.16%	+29.43%	+23.64%	326B
NOVARTIS AG	+1.03%	-0.84%	+29.58%	+45.15%	277B
ASTRAZENECA PLC	+0.49%	-5.44%	+21.00%	+23.80%	263B
NOVO NORDISK A/S	+1.59%	+4.89%	-22.56%	-37.35%	224B
AMGEN INC.	+2.91%	+1.25%	+23.13%	+61.59%	193B
GILEAD SCIENCES, INC.	+1.79%	-0.92%	+21.62%	+72.43%	164B
Average	+1.43%	-3.79%	+26.09%	+55.11%	389.37B
Weighted average by Cap.	+1.35%	-4.31%	+34.60%	+80.27%

Exactus Inc Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

	2022	2023
Net sales	1.63M 1.42M 1.32M 1.21M 2.28M 157M 2.32M 15.68M 6.16M 76.56M 6.11M 5.98M 264M	2.38M 2.08M 1.93M 1.77M 3.35M 230M 3.41M 22.99M 9.03M 112M 8.96M 8.76M 387M
Net income	-9.14M -7.99M -7.39M -6.78M -12.84M -881M -13.06M -88.14M -34.62M -430M -34.33M -33.58M -1.49B	-8.02M -7.01M -6.48M -5.95M -11.25M -772M -11.45M -77.27M -30.35M -377M -30.1M -29.44M -1.3B
Net Debt	17.85M 15.61M 14.43M 13.24M 25.06M 1.72B 25.5M 172M 67.61M 840M 67.05M 65.57M 2.9B	21.53M 18.82M 17.4M 15.97M 30.23M 2.07B 30.75M 208M 81.53M 1.01B 80.85M 79.08M 3.5B